Gene expression analysis for high throughput screening applications

被引:0
|
作者
Pinhasov, A [1 ]
Mei, J [1 ]
Amaratunga, D [1 ]
Amato, FA [1 ]
Lu, H [1 ]
Kauffman, J [1 ]
Xin, H [1 ]
Brenneman, DE [1 ]
Johnson, DL [1 ]
Andrade-Gordon, P [1 ]
Ilyin, SE [1 ]
机构
[1] Johnson & Johnson Pharmaceut Res & Dev LLC, Spring House, PA 19477 USA
关键词
TaqMan; Allegro; RT-PCR; gene expression; cytokines; drug discovery; neurodegenerative diseases; cancer;
D O I
暂无
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
To meet growing needs for high throughput gene expression profiling, we established a new automated high throughput TaqMan RT-PCR method for quantitative mRNA expression analysis. In this method, the Allegro(TM) (Zymark) system conducts all sample tracking and liquid handling steps, and ABI PRISM(R) 7900 HT (Applied Biosystems) is used to conduct real-time determination of the C-t value when amplification of PCR products is first detected and accumulation of inhibitory PCR products is unlikely to occur. The ABI PRISM(R) 7900 HT Sequence Detection System features a real-time PCR instrument with 384-well-plate compatibility and robotic loading, and continuous wavelength detection, which enables the use of multiple fluorophores in a single reaction. The Allegro System offers an assembly line approach with a modular design that allows reconfiguration of the components to accommodate variations in the assay flow. In the present study, we have established and validated a new automated High Throughput (FIT) TaqMan RT-PCR-based method for quantitative mRNA expression analysis. The data demonstrate that HT-Taqman PCR is a powerful tool that can be used for measuring low concentrations of mRNA, and is highly accurate, reproducible, and amenable to high throughput analysis. Results suggest that HT-TaqMan is a reliable method for the quantification of low-expression genes and a powerful tool with FIT capability for target identification/validation, structure-activity relationship (SAR) study, compound selection for efficacy studies, and biomarker identification in drug discovery and development.
引用
收藏
页码:133 / 140
页数:8
相关论文
共 50 条
  • [1] High Throughput Screening of Gene Expression Signatures
    A. Kuklin
    S. Shams
    S. Shah
    Genetica, 2000, 108 : 41 - 46
  • [2] High throughput screening of gene expression signatures
    Kuklin, A
    Shams, S
    Shah, S
    GENETICA, 2000, 108 (01) : 41 - 46
  • [3] Applications of molecular diversity analysis in high throughput screening
    Wikel, JH
    Higgs, RE
    JOURNAL OF BIOMOLECULAR SCREENING, 1997, 2 (02) : 65 - 67
  • [4] High throughput analysis of differential gene expression
    Carulli, JP
    Artinger, M
    Swain, PM
    Root, CD
    Chee, L
    Tulig, C
    Guerin, J
    Osborne, M
    Stein, G
    Lian, J
    Lomedico, PT
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1998, : 286 - +
  • [5] High throughput analysis of gene expression in the human brain
    Colantuoni, C
    Purcell, AE
    Bouton, CML
    Pevsner, J
    JOURNAL OF NEUROSCIENCE RESEARCH, 2000, 59 (01) : 1 - 10
  • [6] High throughput gene expression analysis of the inner ear
    Hertzano, Ronna
    Elkon, Ran
    HEARING RESEARCH, 2012, 288 (1-2) : 77 - 88
  • [7] Identification of differential gene expression by high throughput analysis
    To, KY
    COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING, 2000, 3 (03) : 235 - 241
  • [8] High throughput gene expression screening: Its emerging role in drug discovery
    Freeman, T
    MEDICINAL RESEARCH REVIEWS, 2000, 20 (03) : 197 - 202
  • [9] A method for high-throughput gene expression signature analysis
    David Peck
    Emily D Crawford
    Kenneth N Ross
    Kimberly Stegmaier
    Todd R Golub
    Justin Lamb
    Genome Biology, 7
  • [10] High-throughput gene expression analysis for drug discovery
    Lennon, GG
    DRUG DISCOVERY TODAY, 2000, 5 (02) : 59 - 66